Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martha Hernandez

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Antimicrobial Agents and Chemotherapy|November 1, 2016
Safety, Tolerability, and Pharmacokinetics of MEDI4893, an Investigational, Extended-Half-Life, Anti-Staphylococcus aureus Alpha-Toxin Human Monoclonal Antibody, in Healthy AdultsXiang-Qing Yu, Gabriel J Robbie, Yuling Wu, et al.
RMD Open|April 17, 2018
Pharmacodynamic and pharmacokinetic effects and safety of verinurad in combination with febuxostat in adults with gout: a phase IIa, open-label studyRoy Fleischmann, Peter Winkle, Jesse Hall, et al.
RMD Open|March 14, 2018
Pharmacodynamic and pharmacokinetic effects and safety of verinurad in combination with allopurinol in adults with gout: a phase IIa, open-label studyRoy Fleischmann, Peter Winkle, Jeffrey N Miner, et al.
Proceedings of the Western Pharmacology Society|January 19, 2006
Effects of single administration of diethylstilbestrol on murine langerhans cellsAna Martha Hernandez-Segura, Isai Ayala-Garcia, S Judith Alvarez-Pérez, et al.
Lancet (London, England)|November 10, 2022
LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trialShweta Urva, Tamer Coskun, Mei Teng Loh, et al.
Journal of Diabetes Research|September 19, 2019
Plasma Levels of Free Fatty Acids in Women with Gestational Diabetes and Its Intrinsic and Extrinsic Determinants: Systematic Review and Meta-AnalysisJose Rafael Villafan-Bernal, Mariana Acevedo-Alba, Rodrigo Reyes-Pavon, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 25, 2019
First-in-human clinical trial to assess pharmacokinetics, pharmacodynamics, safety, and tolerability of iscalimab, an anti-CD40 monoclonal antibodyPascal Espié, YanLing He, Phillip Koo, et al.
Thorax|May 1, 2019
Urban airborne particle exposure impairs human lung and blood <i>Mycobacterium tuberculosis</i> immunityMartha Torres, Claudia Carranza, Srijata Sarkar, et al.
Nature Medicine|January 14, 2022
Preclinical development and phase 1 trial of a novel siRNA targeting lipoprotein(a)Michael J Koren, Patrick Maurice Moriarty, Seth J Baum, et al.
Ebiomedicine|July 9, 2022
Safety and immunogenicity of intramuscular, single-dose V590 (rVSV-SARS-CoV-2 Vaccine) in healthy adults: Results from a phase 1 randomised, double-blind, placebo-controlled, dose-ranging trialJonathan A Robbins, Dereck Tait, Qinlei Huang, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Antimicrobial Agents and Chemotherapy|November 1, 2016
Safety, Tolerability, and Pharmacokinetics of MEDI4893, an Investigational, Extended-Half-Life, Anti-Staphylococcus aureus Alpha-Toxin Human Monoclonal Antibody, in Healthy AdultsXiang-Qing Yu, Gabriel J Robbie, Yuling Wu, et al.
RMD Open|April 17, 2018
Pharmacodynamic and pharmacokinetic effects and safety of verinurad in combination with febuxostat in adults with gout: a phase IIa, open-label studyRoy Fleischmann, Peter Winkle, Jesse Hall, et al.
RMD Open|March 14, 2018
Pharmacodynamic and pharmacokinetic effects and safety of verinurad in combination with allopurinol in adults with gout: a phase IIa, open-label studyRoy Fleischmann, Peter Winkle, Jeffrey N Miner, et al.
Proceedings of the Western Pharmacology Society|January 19, 2006
Effects of single administration of diethylstilbestrol on murine langerhans cellsAna Martha Hernandez-Segura, Isai Ayala-Garcia, S Judith Alvarez-Pérez, et al.
Lancet (London, England)|November 10, 2022
LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trialShweta Urva, Tamer Coskun, Mei Teng Loh, et al.
Journal of Diabetes Research|September 19, 2019
Plasma Levels of Free Fatty Acids in Women with Gestational Diabetes and Its Intrinsic and Extrinsic Determinants: Systematic Review and Meta-AnalysisJose Rafael Villafan-Bernal, Mariana Acevedo-Alba, Rodrigo Reyes-Pavon, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 25, 2019
First-in-human clinical trial to assess pharmacokinetics, pharmacodynamics, safety, and tolerability of iscalimab, an anti-CD40 monoclonal antibodyPascal Espié, YanLing He, Phillip Koo, et al.
Thorax|May 1, 2019
Urban airborne particle exposure impairs human lung and blood <i>Mycobacterium tuberculosis</i> immunityMartha Torres, Claudia Carranza, Srijata Sarkar, et al.
Nature Medicine|January 14, 2022
Preclinical development and phase 1 trial of a novel siRNA targeting lipoprotein(a)Michael J Koren, Patrick Maurice Moriarty, Seth J Baum, et al.
Ebiomedicine|July 9, 2022
Safety and immunogenicity of intramuscular, single-dose V590 (rVSV-SARS-CoV-2 Vaccine) in healthy adults: Results from a phase 1 randomised, double-blind, placebo-controlled, dose-ranging trialJonathan A Robbins, Dereck Tait, Qinlei Huang, et al.
Pageof 4